Safe and effective gene therapy strategies depend on robust and reliable adeno-associated virus (AAV) mediated therapeutic gene delivery. However, scaling up AAV manufacturing to obtain sufficient ...
Previous efforts to circumvent the problem of the size limitation imposed by the AAV vector have focused mainly on altering the candidate genes into ‘mini-expression cassettes’ suitable for ...
Let us help you with your inquiries ... is gaining the most attention among them. The AAV viral vectors, as well as messenger RNAs derived from plasmid DNA templates, are crucial steps in the ...
Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System ... an optimized two-plasmid system compatible across ...